+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effect of aging on lazabemide binding, monoamine oxidase activity and monoamine metabolites in human frontal cortex

Effect of aging on lazabemide binding, monoamine oxidase activity and monoamine metabolites in human frontal cortex

Journal Of Neural Transmission General Section. 101(1-3): 83-94

Age-related modifications of monoamine oxidase-A and -B (MAO-A and MAO-B) and amine metabolite concentrations were studied in human frontal cortex taken postmortem from 22 subjects of various ages (2175 years). Qualitative and quantitative analysis for MAO-B was provided by kinetic studies with a specific radioligand, (3H)lazabemide. The data demonstrated a significant (P lt 0.05) positive correlation between the density of (3H)lazabemide binding sites (B-max) and age of the subject, without showing an apparent modification in the dissociation constant (K-D) of the radioligand. In parallel experiments, MAO-B but not MAO-A activity was shown to correlate with age (P lt 0.05). The concentrations of the amine metabolites 4-hydroxy-3-methoxyphenylacetic acid (HVA), 5-hydroxyindole-3-acetic acid (5-HIAA), 3,4-dihydroxyphenylacetic acid (DOPAC), 4-hydroxy-3-methoxyphenylglycol (MHPG) and 3,4-dihydroxyphenylglycol (DHPG) were all devoid of a correlation with age. Neither did the concentrations of these metabolites relate to the respective subject's MAO-B enzymatic activity nor to (3H)lazabemide B-max. A correlation, though rather weak, was obtained between MAO-A activity and MHPG concentration (P = 0.045). The MAO-A and -B enzyme characteristics in subjects who had committed suicide (n = 9) did not differ from those of subjects deceased for other causes (n = 13). Among the measured monoamine metabolites the concentrations of DOPAC and HVA were higher in the suicide versus control group (P lt 0.05). The present data confirm in a direct manner that the increase in MAO-B activity in aging brain is due to an enhancement of the number of active sites of the enzyme and not through modifications of its kinetic characteristics. Furthermore, that neither the characteristics nor the activity of the enzyme are changed in the frontal cortex of suicide victims compared to control subjects.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 008522360

Download citation: RISBibTeXText

PMID: 8695059

DOI: 10.1007/bf01271547

Related references

Specific binding of H-3Ro 19-6327 (lazabemide) to monoamine oxidase B is increased in frontal cortex of suicide victims after controlling. 2008

Specific binding of [3H]Ro 19-6327 (lazabemide) to monoamine oxidase B is increased in frontal cortex of suicide victims after controlling for age at death. European Neuropsychopharmacology 18(1): 55-61, 2007

In vitro effects on monoamine uptake and release by the reversible monoamine oxidase-B inhibitors lazabemide and N-(2-aminoethyl)-p-chlorobenzamide: a comparison with L-deprenyl. Biochemical Pharmacology 50(1): 97-102, 1995

Pharmacokinetics of oral moclobemide in healthy human subjects and effects on monoamine oxidase activity in platelets and excretion of urine monoamine metabolites. European Journal of Clinical Pharmacology 28(1): 89-96, 1985

Monoamine oxidase inhibitors effect on human plasma melatonin blood platelet serotonin content and monoamine oxidase activity. Journal of Clinical Pharmacology 26(7): 552, 1986

Antioxidant activity of the monoamine oxidase B inhibitor lazabemide. Biochemical Pharmacology 60(5): 709-716, 1 September, 2000

Ontogenesis of monoamine oxidase-A and -B in the human brain frontal cortex. Brain Research 499(1): 81-86, 1989

Immunocytochemical localization of serotonin, monoamine oxidase and assessment of monoamine oxidase activity in human dental pulp. Brain Research 853(2): 374-376, Jan 24, 2000

FA-70, a novel selective and irreversible monoamine oxidase-A inhibitor: effect on monoamine metabolism in mouse cerebral cortex. Journal of Pharmacology and Experimental Therapeutics 292(2): 788-794, 2000

Increased activity of monoamine oxidase-B in plaque-associated astrocytes in Alzheimer brain demonstrated by quantitative enzyme autoradiography using 3H-lazabemide. Neurobiology of Aging 15(SUPPL 1): S120-S121, 1994

The deduced amino acid sequences of human platelet and frontal cortex monoamine oxidase B are identical. Journal of Neurochemistry 61(1): 187-190, 1993

Effect of physostigmine on acetylcholine and monoamine metabolites in rat frontal cortex with lesions of the nucleus basalis of Meynert. Rinsho Shinkeigaku 34(3): 224-228, 1994

Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A/monoamine oxidase-B inhibitor in animal models of Parkinson's disease and aging. Neurobiology of Aging 36(3): 1529-1542, 2015

Monoamine content and activity of monoamine oxidase in the brain under the effect of cyclic amp and imidazole. Biologicheskii Zhurnal Armenii 38(3): 222-227, 1985

Effect of Alkaloids Isolated from Phyllodium pulchellum on Monoamine Levels and Monoamine Oxidase Activity in Rat Brain. Evidence-Based Complementary and Alternative Medicine 2016: 6826175, 2016